INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
Overall INFU gets a fundamental rating of 6 out of 10. We evaluated INFU against 102 industry peers in the Health Care Providers & Services industry. INFU scores excellent on profitability, but there are some minor concerns on its financial health. INFU is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make INFU suitable for growth investing!
1. Profitability
1.1 Basic Checks
INFU had positive earnings in the past year.
INFU had a positive operating cash flow in the past year.
In the past 5 years INFU has always been profitable.
INFU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
INFU's Return On Assets of 3.06% is fine compared to the rest of the industry. INFU outperforms 64.71% of its industry peers.
INFU has a better Return On Equity (5.78%) than 62.75% of its industry peers.
The Return On Invested Capital of INFU (7.47%) is better than 72.55% of its industry peers.
INFU had an Average Return On Invested Capital over the past 3 years of 3.86%. This is significantly below the industry average of 9.62%.
The last Return On Invested Capital (7.47%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROIC | 7.47% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU has a better Profit Margin (2.32%) than 62.75% of its industry peers.
In the last couple of years the Profit Margin of INFU has remained more or less at the same level.
Looking at the Operating Margin, with a value of 6.07%, INFU is in the better half of the industry, outperforming 63.73% of the companies in the same industry.
In the last couple of years the Operating Margin of INFU has grown nicely.
INFU has a Gross Margin of 53.13%. This is in the better half of the industry: INFU outperforms 78.43% of its industry peers.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INFU is destroying value.
Compared to 1 year ago, INFU has more shares outstanding
Compared to 5 years ago, INFU has more shares outstanding
Compared to 1 year ago, INFU has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.56 indicates that INFU is not a great score, but indicates only limited risk for bankruptcy at the moment.
INFU has a Altman-Z score of 2.56. This is comparable to the rest of the industry: INFU outperforms 56.86% of its industry peers.
The Debt to FCF ratio of INFU is 12.54, which is on the high side as it means it would take INFU, 12.54 years of fcf income to pay off all of its debts.
INFU has a Debt to FCF ratio of 12.54. This is comparable to the rest of the industry: INFU outperforms 44.12% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that INFU is somewhat dependend on debt financing.
INFU's Debt to Equity ratio of 0.52 is fine compared to the rest of the industry. INFU outperforms 60.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Altman-Z | 2.56 |
ROIC/WACC0.89
WACC8.4%
2.3 Liquidity
A Current Ratio of 2.21 indicates that INFU has no problem at all paying its short term obligations.
The Current ratio of INFU (2.21) is better than 77.45% of its industry peers.
INFU has a Quick Ratio of 1.83. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.83, INFU is doing good in the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 6900.00%, which is quite impressive.
Measured over the past years, INFU shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.59% on average per year.
INFU shows a small growth in Revenue. In the last year, the Revenue has grown by 7.98%.
INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.70% yearly.
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 84.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.03% on average over the next years. This is quite good.
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 44.36 indicates a quite expensive valuation of INFU.
INFU's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of INFU to the average of the S&P500 Index (26.31), we can say INFU is valued expensively.
Based on the Price/Forward Earnings ratio of 18.19, the valuation of INFU can be described as rather expensive.
Based on the Price/Forward Earnings ratio, INFU is valued a bit cheaper than 64.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, INFU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 18.19 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INFU is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
INFU's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.92 | ||
| EV/EBITDA | 7.29 |
4.3 Compensation for Growth
INFU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INFU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 84.76% in the coming years.
PEG (NY)0.55
PEG (5Y)4.19
EPS Next 2Y84.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.21
+0.11 (+1.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.82%
Inst Owner Change-0.34%
Ins Owners3.62%
Ins Owner Change0.69%
Market Cap130.29M
Analysts84
Price Target13.9 (123.83%)
Short Float %2.04%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-48.06%
Max EPS beat(2)75.49%
EPS beat(4)2
Avg EPS beat(4)7.91%
Min EPS beat(4)-48.06%
Max EPS beat(4)75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-4.92%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)-3.54%
PT rev (3m)-3.54%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-20.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.4%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 18.19 | ||
| P/S | 0.95 | ||
| P/FCF | 56.92 | ||
| P/OCF | 5.96 | ||
| P/B | 2.36 | ||
| P/tB | 2.88 | ||
| EV/EBITDA | 7.29 |
EPS(TTM)0.14
EY2.25%
EPS(NY)0.34
Fwd EY5.5%
FCF(TTM)0.11
FCFY1.76%
OCF(TTM)1.04
OCFY16.78%
SpS6.56
BVpS2.63
TBVpS2.16
PEG (NY)0.55
PEG (5Y)4.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROCE | 9.46% | ||
| ROIC | 7.47% | ||
| ROICexc | 7.6% | ||
| ROICexgc | 8.58% | ||
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% | ||
| FCFM | 1.66% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Debt/EBITDA | 1.35 | ||
| Cap/Depr | 151.51% | ||
| Cap/Sales | 14.23% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.77% | ||
| Profit Quality | 71.76% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.56 |
F-Score9
WACC8.4%
ROIC/WACC0.89
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y149.37%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.23%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y64.52%
OCF growth 3Y3.76%
OCF growth 5Y8.08%